4//SEC Filing
Bergmann Anthony 4
Accession 0001415889-25-000876
CIK 0001133869other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 7:00 PM ET
Size
10.0 KB
Accession
0001415889-25-000876
Insider Transaction Report
Form 4
Bergmann Anthony
CHIEF FINANCIAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2025-01-02+6,170→ 6,170 totalExercise: $14.96Exp: 2035-01-02→ Common Stock (6,170 underlying) - Award
Common Stock
2025-01-02+3,342→ 5,723 total - Award
Stock Option (Right to Buy)
2025-01-02+75,000→ 75,000 totalExercise: $14.96Exp: 2035-01-02→ Common Stock (75,000 underlying)
Footnotes (3)
- [F1]Represents fully vested Restricted Stock Units as of January 2, 2025 issued for services with the Company.
- [F2]The shares vest 1/48th of the first day of each month, commencing February 1, 2025, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting.
- [F3]The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant.
Documents
Issuer
CAPRICOR THERAPEUTICS, INC.
CIK 0001133869
Entity typeother
Related Parties
1- filerCIK 0001593087
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 7:00 PM ET
- Size
- 10.0 KB